Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of ASP1517 with Lanthanum Carbonate Hydrate in Healthy Men
NCT02952040Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of roxadustat in anemia of chronic kidney disease (CKD-A) (2 arms), sponsored by Astellas Pharma. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Infinity, Area Under the Concentration-Time Curve from Time Zero to 24 Hours and 1 more. Started Nov 2016; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02952040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02952040.